GlobeNewswire Inc.··Ascentage Pharma Group InternationalAscentage Pharma Showcases Pipeline at ASCO 2026 With Three Oral Presentations
Ascentage Pharma selected for six abstracts at ASCO 2026, including three rapid oral presentations featuring data on three key oncology drug candidates.
AAPGclinical trialsoncology